Suppr超能文献

美国成年抑郁症患者抗抑郁药治疗的持续性。

Continuity of antidepressant treatment for adults with depression in the United States.

作者信息

Olfson Mark, Marcus Steven C, Tedeschi Michael, Wan George J

机构信息

New York State Psychiatric Institute/Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.

出版信息

Am J Psychiatry. 2006 Jan;163(1):101-8. doi: 10.1176/appi.ajp.163.1.101.

Abstract

OBJECTIVE

Continuation of antidepressant treatment for depression beyond the first months helps to consolidate treatment response and to reduce the risk of early relapse. The authors sought to characterize the rate and pattern of antidepressant discontinuation among adults initiating antidepressant treatment for depression.

METHOD

Data were drawn from the household component of the Medical Expenditure Panel Survey for 1996-2001. Analysis was limited to data for adults age 18 years and older (N=829) who initiated antidepressant treatment for depression and who 1) discontinued treatment during the first 30 days of treatment, 2) completed the first 30 days of treatment and then discontinued treatment during the following 60 days, or 3) continued treatment for more than 90 days after treatment initiation.

RESULTS

A majority of the patients discontinued antidepressant therapy during the first 30 days (42.4%). Only 27.6% of the patients continued antidepressant therapy for more than 90 days. Antidepressant discontinuation during the first 30 days of treatment was significantly more common among Hispanics (53.8%) than non-Hispanics (41.3%); patients with fewer than 12 years of education (50.8%), compared with those with 12 or more years (39.3%); and patients with low family incomes (50.2%), compared with those with medium or high family incomes (38.6%). Patients were significantly more likely to continue antidepressant treatment beyond 30 days if they received psychotherapy (68.0% versus 43.7%), completed 12 or more years of education (64.8% versus 52.0%), or had private health insurance (60.1% versus 50.8%). Among those who continued antidepressants beyond 30 days, antidepressant continuity during the subsequent 60 days was significantly associated with fair or poor pretreatment self-rated mental health and physical health, treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor, and psychotherapy.

CONCLUSIONS

Early discontinuation of antidepressant therapy is widespread in the community treatment of depression, especially among socioeconomically disadvantaged patients. Provision of psychotherapy and selection of an appropriate antidepressant medication may reduce the risk of discontinuation during the first 3 months of antidepressant treatment for depression.

摘要

目的

在最初几个月之后继续进行抗抑郁治疗有助于巩固治疗反应并降低早期复发风险。作者试图描述开始接受抑郁症抗抑郁治疗的成年人中抗抑郁药物停药的速率和模式。

方法

数据取自1996 - 2001年医疗支出面板调查的家庭部分。分析仅限于18岁及以上开始接受抑郁症抗抑郁治疗的成年人的数据(N = 829),这些人1)在治疗的前30天内停药,2)完成了前30天的治疗,然后在接下来的60天内停药,或3)在开始治疗后持续治疗超过90天。

结果

大多数患者在最初30天内停用抗抑郁药物治疗(42.4%)。只有27.6%的患者持续抗抑郁治疗超过90天。在治疗的前30天内停用抗抑郁药物在西班牙裔患者中(53.8%)比非西班牙裔患者(41.3%)更为常见;受教育年限少于12年的患者(50.8%),与受教育年限为12年或以上的患者(39.3%)相比;家庭收入低的患者(50.2%),与家庭收入中等或高的患者(38.6%)相比。如果患者接受心理治疗(68.0%对43.7%)、完成12年或以上教育(64.8%对52.0%)或拥有私人医疗保险(60.1%对50.8%),则他们在30天后继续接受抗抑郁治疗的可能性显著更高。在那些30天后继续使用抗抑郁药物的患者中,随后60天内的抗抑郁药物持续性与治疗前自评心理健康和身体健康状况一般或较差、使用选择性5-羟色胺再摄取抑制剂或5-羟色胺-去甲肾上腺素再摄取抑制剂治疗以及心理治疗显著相关。

结论

在社区抑郁症治疗中,抗抑郁药物治疗的早期停药很普遍,尤其是在社会经济处于不利地位的患者中。提供心理治疗和选择合适的抗抑郁药物可能会降低抑郁症抗抑郁治疗前3个月内停药的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验